MAPT and Alzheimer disease: These isoforms have shown promise in distinguishing tau pathology in other neurodegenerative conditions such as AD.36 Additionally, p-tau181 and p-tau217 have demonstrated sensitivity in detecting early tau abnormalities associated with RHI.37 A future study is encouraged to incorporate these tau isoforms to study the potential neurological burden from RHI in middle-aged former athletes.